Summary
- Tabula Rasa HealthCare has agreed to acquire DoseMe for up to $30 million in total consideration.
- DoseMe has developed a dosing software decision support system for IV-administered medications in the hospital setting.
- TRHC will pair the DoseMe solution with its MedWise oral solids system as it seeks to enter the hospital market.
- Looking for a community to discuss ideas with? IPO Edge features a chat room of like-minded investors sharing investing ideas and strategies. Get started today »
Quick Take
Tabula Rasa (TRHC) has agreed to acquire DoseMe for up to $30 million in cash, stock and contingent consideration.
DoseMe has developed decision support software to guide healthcare practitioners to predict the optimal dose of drugs.
TRHC is making its first acquisition as a public company, to fill a gap so it can pursue the hospital dosing decision support market.
